Ergot alkaloids (editorial) by Eskes, T.K.A.B.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/21976
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.
E L S E V I E R
European Journal of Obstetrics & Gynecology 
and Reproductive Biology 60 (1995) 99
GYNEC
Editorial
This issue of EJOGR touches upon an old obstetrical 
story: the history of ergot alkaloids (van Dongen and de 
Groot, 1995, see page —).
The use of ergot as an oxytocic drug originates from 
the classic work of Chassar Moir in the thirties and the 
amine alkaloid has since found its application in the pre­
vention or treatment of postpartum haemorrhage as 
well as bleeding problems like menorrhagia.
The study of De Groot et al. shows that at least oral 
methylergometrine maleate has a late and unpredictable 
effect on the activity of the human uterus during men­
struation. In addition, pharmacokinetic analyses per­
formed on the same women at the time of recording 
showed large individual differences in absorption and in 
the time and values of maximum plasma concentration.
In the same study, the hypothesis is launched that the 
process of menstruation is comparable to the process of
placental separation and expulsion. This is a fascinating 
thought and probably true for intra-uterine pressure 
patterns, spiral arteries, the plane of separation, i.e. the 
basal and functional layers of endometrium and 
decidua, respectively, and the intra-uterine blood coagu­
lation cascade including fibrinolysis and intravascular 
plug formation.
This comparison is certainly not true for the differ­
ences in uterine size and the striking differences in hor­
monal milieu during menstruation and the immediate 
postpartum period. Nevertheless, it seems worthwhile to 
originate further study on the similarities or dissimi­
larities of two periods in reproductive age that so far do 
not have the high priority that these deserve: prevention 
of haemorrhage.
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